I've earmarked this to have a listen to.
Part one of Cancer Trials - Behind The Scenes At The Christie will be broadcast on Radio 5 live on Sunday 7th August from 8.00pm. The second part follows two weeks later on Sunday 21st August at 8.00pm.
http://www.bbc.co.uk/news/health-14421943
However, I'm not so sure about this.
Breast cancer prevention drugs 'should be prescribed'
http://www.bbc.co.uk/news/health-12861988
As with everything, there are 'fors' and 'againsts'.
The report suggest that drugs such as tamoxifen and raloxifene should be prescribed to people who do not have cancer, as a preventive measure - just in case, as they just might be at risk of getting it in the future.
The comments attached to this article are mixed between for and against.
I tend to go with the 'against' comments - (if it's not broke, don't fix it). In fact, I would change that slightly ... If it's not broke, don't meddle with it, cos you could end up breaking it.
Part one of Cancer Trials - Behind The Scenes At The Christie will be broadcast on Radio 5 live on Sunday 7th August from 8.00pm. The second part follows two weeks later on Sunday 21st August at 8.00pm.
"Almost everyone knows someone that has been affected by cancer, so it is vital that clinical trials continue to grow to further improve cancer treatments for all patients around the world. We are working towards a future without cancer and early phase trials are an important contribution to this objective."
Professor John Radford, consultant at The Christie, said the hospital had been at the forefront of cancer research for more than a century.
"Our commitment to clinical trials has led to many advances in cancer research. The life-saving breast cancer drug Tamoxifen, which was first trialled at The Christie more than 40 years ago, is just one of them.
http://www.bbc.co.uk/news/health-14421943
However, I'm not so sure about this.
Breast cancer prevention drugs 'should be prescribed'
http://www.bbc.co.uk/news/health-12861988
As with everything, there are 'fors' and 'againsts'.
The report suggest that drugs such as tamoxifen and raloxifene should be prescribed to people who do not have cancer, as a preventive measure - just in case, as they just might be at risk of getting it in the future.
However, tamoxifen has been linked with womb cancer, blood clots and stroke
Professor Jack Cuzick, who chaired the panel and is an epidemiologist at Queen Mary, University of London, told the BBC: "The two drugs should be approved in the UK. The evidence for them is overwhelming."
He estimates that for every 1000 women given tamoxifen there would be 20 fewer breast cancers, but there would also be three more womb cancers and six more cases of deep vein thrombosis.
The comments attached to this article are mixed between for and against.
I tend to go with the 'against' comments - (if it's not broke, don't fix it). In fact, I would change that slightly ... If it's not broke, don't meddle with it, cos you could end up breaking it.